What is the price of PharmaBlock Sciences (Nanjing), Inc. (300725)

The price of PharmaBlock Sciences (Nanjing), Inc. (300725) is $6.59

What is the market cap of PharmaBlock Sciences (Nanjing), Inc. (300725)

The market cap of PharmaBlock Sciences (Nanjing), Inc. (300725) is $1.54B

PharmaBlock Sciences (Nanjing), Inc. (300725) Dividends

PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical products and specialized services, supporting the pharmaceutical industry across the full spectrum of its operations – from initial research and development phases to large-scale commercial production. The company's primary offerings encompass: A vast inventory of chemical building blocks, available for supply at every stage of drug creation, from early discovery through to advanced development and commercial manufacturing. The creation of diverse chemical libraries, derived from their building blocks, specifically designed to accelerate drug discovery processes. Contract development and manufacturing (CDMO) services for essential pharmaceutical components, including raw starting materials (RSMs), chemical intermediates, active pharmaceutical ingredients (APIs), and finished drug products, catering to both clinical development programs and market demands. Established in 2006, PharmaBlock Sciences maintains its corporate headquarters in Nanjing, People's Republic of China.

Year	Dividend (stock split adjusted)	Change
Not enough data for the provided dates.

Year

Dividend (stock split adjusted)

Change

Not enough data for the provided dates.

Year	Dividend	Change
Not enough data for the provided dates.

Year

Dividend

Change

Not enough data for the provided dates.

Company	Number of dividend payments	Country
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	DE
Merck KGaA MRK.DE	0.00%	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	JP
Galderma Group AG GALD.SW	0.00%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	38.00%	IN

Company

Number of dividend payments

Country